Characterization of the Clinical Evidence Supporting Repository Corticotropin Injection for FDA-Approved Indications-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Characterization of the Clinical Evidence Supporting Repository Corticotropin Injection for FDA-Approved Indications

Published:2022-02-01 Issue:2 Volume:182 Page:206
ISSN:2168-6106
Container-title:JAMA Internal Medicine
language:en
Short-container-title:JAMA Intern Med

Author:

Tran Kim A.¹,Harrod Curtis²,Bourdette Dennis N.³,Cohen David M.⁴,Deodhar Atul A.⁵,Hartung Daniel M.¹

Affiliation:

1. College of Pharmacy, Oregon State University at Oregon Health & Science University, Portland

2. Center for Evidence-based Policy, Oregon Health & Science University, Portland

3. Department of Neurology, Oregon Health & Science University, Portland

4. Division of Nephrology and Hypertension, Department of Medicine, Oregon Health & Science University, Portland

5. Division of Arthritis and Rheumatic Diseases, Department of Medicine, Oregon Health & Science University, Portland

Publisher

American Medical Association (AMA)

Subject

Internal Medicine

Link

https://jamanetwork.com/journals/jamainternalmedicine/articlepdf/2787088/jamainternal_tran_2021_rv_210001_1643648274.28546.pdf

Reference75 articles.

1. Repository corticotropin versus glucocorticoid for nephrotic syndrome: when will we see the evidence?;Hartung;Am J Kidney Dis,2019

2. Corticotropin for parenteral use: drugs for human use: drug efficacy study implementation.;Fed Regist,1971

3. Older drugs with limited trial evidence: are they worth the expense? the case of repository corticotropin marketed as H. P. Acthar Gel.;Duarte-García;Ann Intern Med,2019

4. Trends and characteristics of US Medicare spending on repository corticotropin.;Hartung;JAMA Intern Med,2017

5. Older drugs with limited trial evidence: are they worth the expense?;Hartung;Ann Intern Med,2019

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Off-Label Use vs Off-Label Marketing;JACC: Basic to Translational Science;2023-03

2. FDA-APPROVED INDICATIONS OF ADRENOCORTICOTROPIC HORMONE (ACTH) AS A DRUG: DOES IT HAVE A PLACE IN DISEASE MANAGEMENT TODAY?;Central Asian Journal of Medical Hypotheses and Ethics;2023-02-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3